Skip to main content
CriticalFDAfda-F-0914-2018UNDECLARED ALLERGEN

Xenesta Nuvive Mens 90 count packaged in an white plastic bottle with white cap

⚠ Critical Alert — Stop Using Immediately

This product has been flagged with severe risks (undeclared allergen). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.

Category
Units Affected
88
Recall Date
February 23, 2018
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0914-2018.

Recalled dietary supplements may contain undeclared milk.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0914-2018.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Progressive Laboratories, Inc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0914-2018.

Progressive Laboratories, Inc

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Progressive Laboratories, Inc Recall FAQ

Progressive Laboratories, Inc is the subject of a food safety report: Xenesta Nuvive Mens 90 count packaged in an white plastic bottle with white cap. The notice was published on February 23, 2018 by the U.S. Food and Drug Administration (FDA). Approximately 88 units are potentially affected.